Investment
Features
FeesSafety
Academy
More
Pluang+

Chord Energy beats Q2 expectations with strong free cash flow and share buybacks, raising its fair value to $210.

Company Fundamentals
17 Aug 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Chord Energy demonstrated strong Q2 results by exceeding free cash flow expectations and hitting high oil production targets. The company reduced its share count significantly through aggressive buybacks, enhancing per-share value. Management plans to return at least 75% of adjusted free cash flow to shareholders starting Q3, mainly via buybacks, while maintaining a $1.30 quarterly dividend. These disciplined capital allocation strategies support a Buy rating and an increased fair value estimate of around $210 per share.

More News

Robotera plans Hong Kong IPO after raising $340M and targeting 1,000+ robot deliveries in 2026

Robotera plans Hong Kong IPO after raising $340M and targeting 1,000+ robot deliveries in 2026

Robotera, a Beijing-based robotics startup, plans to go public in Hong Kong following a strong funding year with over $340 million raised in 2026. The company, which designs and manufactures most of its own robot parts, aims to deliver more than 1,00...

Market News
Bullish
4 hours ago
BitMart users and staff demand asset disclosure and repayment plan amid withdrawal issues and unpaid salaries.

BitMart users and staff demand asset disclosure and repayment plan amid withdrawal issues and unpaid salaries.

BitMart users and employees have publicly demanded the crypto exchange disclose its financial reserves, explain withdrawal restrictions, and provide a detailed repayment plan by August 19. This follows reports of users unable to withdraw funds and em...

Market News
Bearish
4 hours ago
New AstraZeneca drug combo extends survival in tough lung cancer cases, offering a chemo alternative.

New AstraZeneca drug combo extends survival in tough lung cancer cases, offering a chemo alternative.

AstraZeneca announced positive late-stage trial results for a two-drug combination treating a resistant form of lung cancer. The combo pairs Tagrisso, an established lung cancer pill, with Orpathys, a newer drug targeting the MET protein that causes ...

Market News
Bullish
4 hours ago
Edge Total Intelligence reports Q2 revenue growth up to 377%, plans share consolidation and strategic expansion.

Edge Total Intelligence reports Q2 revenue growth up to 377%, plans share consolidation and strategic expansion.

Edge Total Intelligence Inc. announced strong preliminary revenue growth for Q2 2026, with year-over-year increases between 313% and 377%, reaching up to $1.95 million. The company also reported improved gross margins as revenue growth outpaced cost ...

Company Fundamentals
Bullish
4 hours ago
FET token falls 5.82%, breaks key support amid heavy selling and Binance outflows

FET token falls 5.82%, breaks key support amid heavy selling and Binance outflows

Artificial Superintelligence Alliance (FET) token dropped 5.82% to $0.125, breaking below a key support level of $0.1311 due to intensified selling pressure and broader AI token repricing. Despite ongoing ecosystem development, investors demand stron...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App